EGFR and head and neck squamous cell carcinoma: Thus, EGFR/ERBB inhibition in HNSCC cells results in elaboration of chemokines and cytokines involved in paracrine signaling to the immune microenvironment as well as increased expression of proteins that function to present neoantigens to T cells.